Ozonated Oil in Liposome Eyedrops Reduces the Formation of Biofilm, Selection of Antibiotic-Resistant Bacteria, and Adhesion of Bacteria to Human Corneal Cells.
antimicrobial agents
antiseptic
biofilm
chlorhexidine
liposomal ozonated oil
multidrug-resistant organisms
ophthalmology
povidone-iodine
toxicity
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Sep 2023
14 Sep 2023
Historique:
received:
01
08
2023
revised:
09
09
2023
accepted:
12
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The recent attention to the risk of potential permanent eye damage triggered by ocular infections has been leading to a deeper investigation of the current antimicrobials. An antimicrobial agent used in ophthalmology should possess the following characteristics: a broad antimicrobial spectrum, prompt action even in the presence of organic matter, and nontoxicity. The objective of this study is to compare the antimicrobial efficacy of widely used ophthalmic antiseptics containing povidone-iodine, chlorhexidine, and liposomes containing ozonated sunflower oil. We determined the minimum inhibitory concentration (MIC) on various microbial strains:
Identifiants
pubmed: 37762377
pii: ijms241814078
doi: 10.3390/ijms241814078
pmc: PMC10531138
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : University of Ferrara
ID : FAR 2021
Références
Transl Vis Sci Technol. 2020 Jul 02;9(8):4
pubmed: 32855851
Case Rep Ophthalmol. 2018 May 24;9(2):287-298
pubmed: 29928225
Am J Ophthalmol. 2011 Oct;152(4):567-574.e3
pubmed: 21652021
J Cataract Refract Surg. 2008 May;34(5):814-8
pubmed: 18471638
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):289-293
pubmed: 34427741
J Appl Microbiol. 2021 Dec;131(6):2626-2639
pubmed: 33650748
Dermatology. 1997;195 Suppl 2:29-35
pubmed: 9403252
Microb Biotechnol. 2022 May;15(5):1422-1433
pubmed: 34773386
Ophthalmol Ther. 2022 Apr;11(2):503-520
pubmed: 35113406
Curr Opin Ophthalmol. 2018 Jan;29(1):19-32
pubmed: 28984794
Int Wound J. 2017 Feb;14(1):172-179
pubmed: 26968574
Int Immunopharmacol. 2018 Mar;56:235-241
pubmed: 29414657
J Cataract Refract Surg. 2001 Jun;27(6):941-7
pubmed: 11408145
Invest Ophthalmol Vis Sci. 2013 Jun 04;54(6):3852-6
pubmed: 23674759
Mycoses. 2011 Sep;54(5):e272-7
pubmed: 20492527
Anaesth Intensive Care. 2008 Jul;36(4):502-12
pubmed: 18714617
Ophthalmology. 2016 Dec;123(12):2588-2594
pubmed: 27720552
BMC Infect Dis. 2019 Sep 3;19(1):768
pubmed: 31481023
Exp Eye Res. 2019 Dec;189:107848
pubmed: 31634477
JAMA Ophthalmol. 2015 Dec;133(12):1445-54
pubmed: 26502312
BMC Ophthalmol. 2017 Aug 22;17(1):151
pubmed: 28830451
Dermatology. 1997;195 Suppl 2:14-8
pubmed: 9403250
Antiviral Res. 2002 May;54(2):89-97
pubmed: 12062394
Expert Rev Anti Infect Ther. 2005 Feb;3(1):131-9
pubmed: 15757463
Phytomedicine. 2019 Apr;57:339-351
pubmed: 30826631
J Vis Exp. 2011 May 16;(51):
pubmed: 21633326
Antibiotics (Basel). 2021 May 21;10(6):
pubmed: 34063833
Cell Host Microbe. 2009 Jun 18;5(6):580-92
pubmed: 19527885
Heliyon. 2018 Dec 28;4(12):e01067
pubmed: 30619958
Mycoses. 2002 Oct;45(8):329-32
pubmed: 12572723
Molecules. 2020 Aug 07;25(16):
pubmed: 32784722
Molecules. 2020 Jan 14;25(2):
pubmed: 31947580
Retina. 2018 Oct;38(10):2064-2066
pubmed: 28796148
JAMA. 2016 Sep 20;316(11):1193-1204
pubmed: 27654605
Invest Ophthalmol Vis Sci. 1980 Mar;19(3):308-13
pubmed: 7358482
Clin Ophthalmol. 2022 Jun 14;16:1953-1962
pubmed: 35726319
Am J Ophthalmol. 2004 Mar;137(3):453-8
pubmed: 15013867
J Phys Chem A. 2015 Mar 19;119(11):2318-25
pubmed: 25188402